WebThinkCyte develops Ghost Cytometry technology, a high-throughput image-based cell sorting system that integrates advanced imaging, machine learning, and microfluidics technologies. It enables researchers to identify cells based on their images and isolate target cells, including rare cells, in real-time. ... WebApr 10, 2024 · ThinkCyte to Showcase VisionSort at the 2024 American Association for Cancer Research (AACR) Annual Meeting. Press. Mar 3, 2024 . ThinkCyte reveals …
ThinkCyte - Updates, News, Events, Signals & Triggers - CrunchBase
WebMay 19, 2024 · TOKYO, May 19, 2024 /PRNewswire/ -- ThinkCyte Secures $26 million in Series B Financing WebThinkCyte has raised a total of ¥5.1B in funding over 4 rounds. Their latest funding was raised on May 19, 2024 from a Series B round. ThinkCyte is funded by 11 investors. … free editing software for youtube shorts
In vitro Diagnostics Market Size, Share & Trends, 2029
WebJoin us to push the frontiers of human knowledge and understanding to shape the future of biology and medicine. Our values, philosophy, and drive are based upon the desire to … WebSysmex and ThinkCyte will integrate Sysmex’s wide knowledge and expertise in in vitro diagnostics with ThinkCyte’s highly innovative Ghost Cytometry technology to develop … WebApr 1, 2024 · Thinkcyte Inc. and Sysmex Corporation(0.53) Thinkcyte Inc.0.45 Sysmex Corporation0.08 Top 10 international collaborators with Thinkcyte Inc. by Share (0 total) Thinkcyte Inc., Japan blount county al probate land records